Bibliographical noteFunding Information:
GF—received in the past 3 years consultancy fees from Abbvie and Lilly. RCK—received in the past 3 years consultancy fees from Alnylam. MLG—received in the past 3 years an AbbVie investigator-initiated research grant and honoraria, Samsung honoraria. LP, DAC, RNB, BY, AI, OK—None. PC—received in the past 3 years speaker fees, consultancy fees or grants from Abbvie, Amgen, Janssen, Takeda and Viatris. VMNL—received in past 3 years speaker fees, consultancy fees or grants from Abbvie, Rb, Nestle Health Science, Ordesa, Lactalis and Adacyte Therapeutics. JHM—None. FR—received in past 3 years consultancy fees from Adnovate, Agomab, Allergan, AbbVie, Arena, Boehringer-Ingelheim, Celgene/BMS, CDISC, Celsius, Cowen, Ferring, Galapagos, Galmed, Genentech, Gilead, Gossamer, Guidepoint, Helmsley, Horizon Therapeutics, Image Analysis Limited, Index Pharma, Jannsen, Koutif, Mestag, Metacrine, Mopac, Morphic, Organovo, Origo, Pfizer, Pliant, Prometheus Biosciences, Receptos, RedX, Roche, Samsung, Surmodics, Surrozen, Takeda, Techlab, Theravance, Thetis, UCB, Ysios and 89Bio. AMG—received in the past 3 years consultancy fees from Abbvie, Amgen, Bristol Myers Squibb, Lilly, Janssen, Merck, Pfizer, Takeda; speaker fees from Abbvie, Janssen; investigator-initiated research grant from Abbvie. DT—received in the past 3 years consultancy fees, research grant, royalties or honorarium from Janssen, Pfizer, Hospital for Sick Children, Ferring, Abbvie, Takeda, Atlantic Health, Shire, Celgene, Lilly, Roche, ThermoFisher, BMS. Acknowledgments
The ImageKids study was supported by an educational grant from AbbVie (grant number IMM-11-0077), which was not involved in any part of the study including protocol preparation, data acquisition, analyses or manuscript preparation.
© 2023 Oxford University Press. All rights reserved.
- Crohn's disease
- Lemann score